Want to see POCI full AI Analyst Report?
POCI Stock Chart & Stats
$4.30
$0.00(0.00%)
At close: 4:00 PM EDT
$4.30
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$3.55 - $6.15
Previous Close$4.35
Volume24.84K
Average Volume (3M)22.99K
Market Cap
$46.41M
Enterprise Value$38.34M
Total Cash (Recent Filing)$10.68M
Total Debt (Recent Filing)$4.28M
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Sep 24, 2026EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.66
Shares Outstanding10,944,869
10 Day Avg. Volume30,022
30 Day Avg. Volume22,992
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)2.71
Price to Sales (P/S)1.74
P/FCF Ratio-8.82
Enterprise Value/Market Cap0.83
Enterprise Value/Revenue1.32
Enterprise Value/Gross Profit9.57
Enterprise Value/Ebitda-8.54
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Raised Revenue GuidanceManagement raised FY2026 revenue guidance materially, reflecting durable demand acceleration and larger production ramps. Sustained guidance upgrades indicate expanding commercial traction and a clearer path to scale, supporting multi-quarter revenue visibility and resource planning for capacity and programs.
Margin And EBITDA InflectionQ3 delivered positive adjusted EBITDA and materially improved gross margin, driven by yield and throughput gains. This operational inflection reduces structural cash burn risk and suggests recurring-profit potential as yields, scale and higher-margin product mix continue improving over the next several quarters.
Reinforced Cash RunwayThe oversubscribed $10M raise meaningfully strengthened the balance sheet, providing runway to fund production scale, yield improvements and facility upgrades. A healthier cash position reduces short-term financing risk and gives management flexibility to execute multi-quarter operational initiatives.
Bears Say
Negative Operating And Free Cash FlowThe business remains a net cash consumer on a trailing basis, with free cash flow deteriorating versus prior periods. Persistent negative cash generation limits reinvestment ability, raises the prospect of further financings if margins slip, and constrains durable self-funding of growth absent sustained profitability.
Ongoing Net Losses And Weak MarginsDespite recent quarter improvements, TTM margins and profitability remain materially negative. Continued negative returns mean the balance sheet is funding unprofitable operations; until margins sustainably convert positive, capital efficiency and shareholder returns will be constrained over the medium term.
Customer Concentration & Disclosure LimitsHigh revenue concentration and limited customer disclosure increase downside sensitivity: large account demand shifts or operational pauses can materially affect results. This structural dependence reduces revenue predictability and negotiating leverage, elevating execution risk across upcoming production ramps.
Precision Optics Corporation News
POCI FAQ
What was Precision Optics Corporation’s price range in the past 12 months?
Precision Optics Corporation lowest stock price was $3.55 and its highest was $6.15 in the past 12 months.
What is Precision Optics Corporation’s market cap?
Precision Optics Corporation’s market cap is $46.41M.
When is Precision Optics Corporation’s upcoming earnings report date?
Precision Optics Corporation’s upcoming earnings report date is Sep 24, 2026 which is in 48 days.
How were Precision Optics Corporation’s earnings last quarter?
Precision Optics Corporation released its earnings results on May 13, 2026. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
Is Precision Optics Corporation overvalued?
According to Wall Street analysts Precision Optics Corporation’s price is currently Overvalued.
Does Precision Optics Corporation pay dividends?
Precision Optics Corporation does not currently pay dividends.
What is Precision Optics Corporation’s EPS estimate?
Precision Optics Corporation’s EPS estimate is -0.06.
How many shares outstanding does Precision Optics Corporation have?
Precision Optics Corporation has 10,944,869 shares outstanding.
What happened to Precision Optics Corporation’s price movement after its last earnings report?
Precision Optics Corporation reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.913%.
Which hedge fund is a major shareholder of Precision Optics Corporation?
Currently, no hedge funds are holding shares in POCI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Precision Optics Corporation Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.78%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
71.67%
Trailing 12-Months
Company Description
Precision Optics Corporation
Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature medical cameras, and cutting-edge 3D endoscopes, all designed for application in minimally invasive surgical procedures carried out by hospitals and healthcare professionals. Beyond its medical division, POCI also produces individual parts and integrated assemblies for industrial and military purposes. POCI markets its medical device portfolio primarily to other corporations within the medical technology sector. Established in 1982, the firm's headquarters are located in Gardner, Massachusetts.
POCI Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated strong operational momentum and important financial inflection points: record revenue, materially improved gross margins, and positive adjusted EBITDA in Q3, supported by manufacturing yield gains, Ross Optical growth and a reinforced cash position from a $10M offering. Management increased full-year revenue guidance and outlined a robust pipeline with multiple programs expected to enter production. Key near-term risks include a customer-requested aerospace production slowdown (estimated 15%–20% pullback in early FY2027), remaining yield improvements needed on the cystoscope line, and facility modernization requirements. On balance, the positive operational and financial progress significantly outweighs the contained challenges, indicating constructive near-term trajectory toward sustained profitability.View all POCI earnings summariesTechnical Analysis
Ownership Overview
5.27% Insiders
17.49% Mutual Funds
0.21% Other Institutional Investors
73.83% Public Companies and
Individual Investors